苹果和 Masimo 的法律诉讼现已向前迈出了一小步

特拉华州陪审团裁定智能手表制造商 Masimo 侵犯了苹果 Apple Watch 的健康技术专利，但仅限于不再销售的旧款智能手表，并在合法范围内判给该公司最小的损害赔偿。

A Delaware jury has found smartwatch maker Masimo guilty of infringing two of Apple's Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and awarded the firm the least damages it legally could.

特拉华州陪审团裁定智能手表制造商 Masimo 侵犯了苹果 Apple Watch 的两项健康技术专利，但仅限于不再销售的旧款智能手表，并在合法范围内判给该公司最小的损害赔偿。

In the suit just decided, Apple accused Masimo in 2022 of infringing two of its own design patents to "make way for its own watch." The jury has now found Masimo guilty of the charge for Masimo's former Freedom and W1 smartwatches, but said the company was not guilty of infringement on any current products.

在刚刚判决的诉讼中，苹果公司指控Masimo在2022年侵犯了自己的两项设计专利，以“为自己的手表让路”。陪审团现已裁定 Masimo 对 Masimo 之前的 Freedom 和 W1 智能手表的指控有罪，但表示该公司对任何当前产品均不存在侵权行为。

It awarded Apple a token $250 in damages, the legal minimum for infringement. Apple's attorneys had sought a sales injunction against current Masimo products it said were infringing Apple's patents, but that charge was denied by the jury, Reuters has reported.

它判苹果象征性地赔偿 250 美元，这是侵权的法定最低赔偿额。据路透社报道，苹果公司的律师曾寻求针对当前 Masimo 产品的销售禁令，称其侵犯了苹果公司的专利，但陪审团否认了这一指控。

Apple said in a statement that it was pleased that the ruling "will protect the innovations we advance on behalf of our customers." Masimo said that "Apple primarily sought an injunction against Masimo's current products, and the jury's verdict is a victory for Masimo on that issue."

苹果在一份声明中表示，很高兴该裁决“将保护我们代表客户推进的创新”。马西莫表示，“苹果主要寻求针对马西莫当前产品的禁令，陪审团的裁决是马西莫在这个问题上的胜利。”

Calling Apple's suit retaliatory, Masimo noted that the jury ruled on its behalf on "nearly" all the disputed issues, and that the patent infringement decision applied only "a discontinued module and charger."

马西莫称苹果公司的诉讼是报复性的，并指出陪审团代表其对“几乎”所有有争议的问题做出了裁决，并且专利侵权裁决仅适用于“已停产的模块和充电器”。

The two companies have been embroiled in a fight over smartwatch health technology. Masimo has previously accused Apple of hiring away its employees and copying aspects of its pulse oximetry technology following failed collaboration talks.

两家公司卷入了智能手表健康技术之争。马西莫此前曾指责苹果公司在合作谈判失败后挖走了其员工并抄袭其脉搏血氧仪技术的某些方面。

Masimo scored a significant victory in its claims in 2023, when the US International Trade Commission temporarily blocked imports of Apple's Series 9 and Ultra 2 watches. Apple is appealing that verdict, but complied with the ITC ruling by disabling the feature.

Masimo 在 2023 年的索赔中取得了重大胜利，当时美国国际贸易委员会暂时阻止了苹果 Series 9 和 Ultra 2 手表的进口。苹果公司正在对该判决提出上诉，但遵守了国际贸易委员会的裁决，禁用了该功能。

It was then was able to resume sales of the Apple Watch. Current models of the Apple Watch continue to include the blood oxygen sensing technology, but it remains disabled until the dispute is settled.

随后苹果手表的销售得以恢复。目前的 Apple Watch 型号继续配备血氧传感技术，但在争议解决之前该技术仍处于禁用状态。

Users with older Apple Watch models, up to the Apple Watch Series 8, can still use the disputed blood oxygen measuring feature.

使用较旧 Apple Watch 型号（直至 Apple Watch Series 8）的用户仍然可以使用有争议的血氧测量功能。

Apple could appeal this most recent decision, forcing the dispute to take longer to resolve. Masimo has now won decisive victories against Apple with both the ITC and a juried trial, which may be enough to get Apple executives to rethink its current legal strategy.

苹果可能会对最新的决定提出上诉，从而迫使争议需要更长的时间才能解决。马西莫现在在国际贸易委员会和陪审团审判中都赢得了针对苹果的决定性胜利，这可能足以让苹果高管重新考虑其当前的法律策略。

Separately, Masimo's CEO stepped down from the role in September 2024. Joe Kiani's move was not, however, related to the Apple Watch dispute.

另外，Masimo 的首席执行官于 2024 年 9 月辞去了这一职务。不过，Joe Kiani 的举动与 Apple Watch 纠纷无关。